These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36314638)
1. Transportation into an Entertainment Narrative about the MMR Vaccine: An Investigation of Self-Referencing and Issue-Related Thoughts in Narrative Persuasion. Moyer-Gusé E; Rader K; Lavis S J Health Commun; 2022 Aug; 27(8):585-592. PubMed ID: 36314638 [TBL] [Abstract][Full Text] [Related]
2. Vaccines for measles, mumps, rubella, and varicella in children. Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885 [TBL] [Abstract][Full Text] [Related]
3. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Nolan T; McIntyre P; Roberton D; Descamps D Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703 [TBL] [Abstract][Full Text] [Related]
4. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Bart KJ; Orenstein WA; Hinman AR Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117 [TBL] [Abstract][Full Text] [Related]
5. Measles, mumps, rubella prevention: how can we do better? Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442 [TBL] [Abstract][Full Text] [Related]
6. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study]. He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468 [No Abstract] [Full Text] [Related]
7. Reducing COVID-19 vaccine hesitancy among African Americans: the effects of narratives, character's self-persuasion, and trust in science. Huang Y; Green MC J Behav Med; 2023 Apr; 46(1-2):290-302. PubMed ID: 35305206 [TBL] [Abstract][Full Text] [Related]
8. Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. Tabacchi G; Costantino C; Napoli G; Marchese V; Cracchiolo M; Casuccio A; Vitale F; Hum Vaccin Immunother; 2016 Jul; 12(7):1909-23. PubMed ID: 27163657 [TBL] [Abstract][Full Text] [Related]
9. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers. Hyle EP; Rao SR; Bangs AC; Gastañaduy P; Fiebelkorn AP; Hagmann SHF; Walker AT; Walensky RP; Ryan ET; LaRocque RC JAMA Pediatr; 2020 Feb; 174(2):e194515. PubMed ID: 31816033 [TBL] [Abstract][Full Text] [Related]
10. Transportation into narrative worlds: implications for entertainment media influences on tobacco use. Green MC; Clark JL Addiction; 2013 Mar; 108(3):477-84. PubMed ID: 22994374 [TBL] [Abstract][Full Text] [Related]
11. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Wellington K; Goa KL Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524 [TBL] [Abstract][Full Text] [Related]
12. Parental attitudes and decisions regarding MMR vaccination during an outbreak of measles among an undervaccinated Somali community in Minnesota. Christianson B; Sharif-Mohamed F; Heath J; Roddy M; Bahta L; Omar H; Rockwood T; Kenyon C Vaccine; 2020 Oct; 38(45):6979-6984. PubMed ID: 32981779 [TBL] [Abstract][Full Text] [Related]
13. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children. Lee CY; Tang RB; Huang FY; Tang H; Huang LM; Bock HL Int J Infect Dis; 2002 Sep; 6(3):202-9. PubMed ID: 12718836 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial. Nakayama T; Eda M; Hirano M; Goto W Hum Vaccin Immunother; 2019; 15(5):1139-1144. PubMed ID: 30724658 [TBL] [Abstract][Full Text] [Related]
15. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy]. Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912 [TBL] [Abstract][Full Text] [Related]
16. Successes and challenges for preventing measles, mumps and rubella by vaccination. Bankamp B; Hickman C; Icenogle JP; Rota PA Curr Opin Virol; 2019 Feb; 34():110-116. PubMed ID: 30852425 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. Lazar M; Stănescu A; Penedos AR; Pistol A Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098 [TBL] [Abstract][Full Text] [Related]
18. Measles, mumps and rubella: control by vaccination. van Druten JA; de Boo T; Plantinga AD Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [TBL] [Abstract][Full Text] [Related]
19. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129 [TBL] [Abstract][Full Text] [Related]
20. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]